- Home
- ABAT vs PYXS Comparison
ABAT vs PYXS Comparison
Compare ABAT & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- PYXS
- Stock Information
- Founded
- ABAT 2011
- PYXS 2018
- Country
- ABAT United States
- PYXS United States
- Employees
- ABAT N/A
- PYXS N/A
- Industry
- ABAT Metal Mining
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- ABAT Basic Materials
- PYXS Health Care
- Exchange
- ABAT Nasdaq
- PYXS Nasdaq
- Market Cap
- ABAT 87.2M
- PYXS 75.0M
- IPO Year
- ABAT N/A
- PYXS 2021
- Fundamental
- Price
- ABAT $2.20
- PYXS $1.10
- Analyst Decision
- ABAT
- PYXS Strong Buy
- Analyst Count
- ABAT 0
- PYXS 5
- Target Price
- ABAT N/A
- PYXS $9.00
- AVG Volume (30 Days)
- ABAT 7.8M
- PYXS 387.8K
- Earning Date
- ABAT 09-22-2025
- PYXS 08-13-2025
- Dividend Yield
- ABAT N/A
- PYXS N/A
- EPS Growth
- ABAT N/A
- PYXS N/A
- EPS
- ABAT N/A
- PYXS N/A
- Revenue
- ABAT $1,857,877.00
- PYXS N/A
- Revenue This Year
- ABAT $718.34
- PYXS N/A
- Revenue Next Year
- ABAT $1,505.37
- PYXS N/A
- P/E Ratio
- ABAT N/A
- PYXS N/A
- Revenue Growth
- ABAT N/A
- PYXS N/A
- 52 Week Low
- ABAT $0.73
- PYXS $0.83
- 52 Week High
- ABAT $4.11
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- ABAT 49.98
- PYXS 43.52
- Support Level
- ABAT $2.15
- PYXS $1.12
- Resistance Level
- ABAT $3.89
- PYXS $1.38
- Average True Range (ATR)
- ABAT 0.43
- PYXS 0.08
- MACD
- ABAT -0.07
- PYXS -0.01
- Stochastic Oscillator
- ABAT 24.55
- PYXS 5.08
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.